Solventum Corp | SOLV - Stammkapital

Aktienkurs
68.58
Täglich Wechseln
1.44 2.14%
Monatlich
-8.45%
Jährlich
-8.92%
Q1 Prognose
64.74




Stammkapital Veränderung Datum
Abbott USD 1.74B 23.39B 2025-09
Align Technology USD 71.75M 736K 2025-12
Baxter International USD 514.28M 168.72M 2025-12
Becton, Dickinson and Co. USD 284.91M 1.72M 2025-12
Cencora USD 2.97M 9K 2024-12
Dexcom USD 384.8M 5.2M 2025-12
Insulet USD 70.35M 1000 2025-12
Solventum Corp USD 173.49M 51.34K 2025-12
West Pharmaceutical Services USD 72M 100K 2025-12
Zimmer Biomet Holdings USD 198.18M 18.44K 2025-12